Bath Cancer Limited 12322699 false 2024-12-01 2025-11-30 2025-11-30 The principal activity of the company is Provision of specialist medical services Digita Accounts Production Advanced 6.30.9574.0 true 12322699 2024-12-01 2025-11-30 12322699 2025-11-30 12322699 bus:Director1 1 2025-11-30 12322699 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 12322699 bus:Micro-entities 2024-12-01 2025-11-30 12322699 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 12322699 bus:FilletedAccounts 2024-12-01 2025-11-30 12322699 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 12322699 bus:RegisteredOffice 2024-12-01 2025-11-30 12322699 bus:Director1 2024-12-01 2025-11-30 12322699 bus:Director1 1 2024-12-01 2025-11-30 12322699 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 12322699 bus:Agent1 2024-12-01 2025-11-30 12322699 countries:UnitedKingdom 2024-12-01 2025-11-30 12322699 bus:Director1 1 2024-11-30 12322699 2023-12-01 2024-11-30 12322699 2024-11-30 12322699 bus:Director1 1 2024-11-30 12322699 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 12322699 bus:Director1 1 2023-12-01 2024-11-30 12322699 bus:Director1 1 2023-11-30 iso4217:GBP xbrli:pure

Registration number: 12322699

Bath Cancer Limited

Unaudited Filleted Financial Statements

for the Year Ended 30 November 2025

 

Bath Cancer Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Bath Cancer Limited

Company Information

Director

Dr Rebecca Louise Bowen

Registered office

9 Penn Lea Road
Bath
BA1 3RF

Accountants

PRWS (Bristol) Limited
Chartered Certified Accountants102 Weston Road
Long Ashton
Bristol
BS41 9BZ

 

Bath Cancer Limited

(Registration number: 12322699)
Balance Sheet as at 30 November 2025

2025
£

2024
£

Fixed assets

506

675

Current assets

406,828

315,651

Prepayments and accrued income

1,008

-

Creditors: Amounts falling due within one year

(953)

(29,145)

Net current assets

406,883

286,506

Total assets less current liabilities

407,389

287,181

Accruals and deferred income

(1,174)

(1,024)

 

406,215

286,157

Capital and reserves

406,215

286,157

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
9 Penn Lea Road
Bath
BA1 3RF

These financial statements were authorised for issue by the director on 9 August 2026.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

3

Related party transactions

Transactions with the director

2025

At 1 December 2024
£

Repayments by director
£

At 30 November 2025
£

Dr Rebecca Louise Bowen

Balance owed to the Director by the company on which no interest has been paid

7,904

(7,904)

-

 

Bath Cancer Limited

(Registration number: 12322699)
Balance Sheet as at 30 November 2025

2024

At 1 December 2023
£

Advances to director
£

Repayments by director
£

At 30 November 2024
£

Dr Rebecca Louise Bowen

Balance owed to the Director by the company on which no interest has been paid

3,064

7,904

(3,064)

7,904

For the financial year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 9 August 2026
 

.........................................
Dr Rebecca Louise Bowen
Director